Coordinator's welcome
Nanomedicine, and the application of nanotechnology to the development of new diagnostics and therapy and the improvement of existing ones, has been identified as a priority of the strategic agendas of OECD and emerging countries. Its implementation is focused on improving the quality of patient service, enabling technology to move towards more personalized care, at an affordable cost, offering competitive products with high added value.
Read moreWith the support of:
La 2ª Escuela de Otoño NanoFar tendrá lugar del 21 al 25 de Octubre de 2013 en la Universidad de Santiago de Compostela (USC).
La primera edición de esta Escuela de Nanomedicina: NANOSISTEMAS DENDRÍTICOS COMO AGENTES Y VECTORES TERAPÉUTICOS PARA SU USO EN DISTINTAS APLICACIONES BIOMÉDICAS se celebrará el próximo 16 de mayo en la Facultad de Farmacia de la Universidad de Alcalá (Madrid).
Read more...
El pasado 19 de abril, el Consejo de Ministros nombró a María Luisa Castaño nueva directora general de Innovación y Competitividad, tras la salida de este cargo el pasado 5 de abril de María Luisa Poncela, actual secretaria general de Ciencia.
El International Iberian Nanotechnology Laboratory (INL) abre 16 nuevos puestos para investigadores
El prestigioso instituto International Iberian Nanotechnology Laboratory (INL) oferta un total de dieciséis nuevos puestos de trabajo para investigadores. Éstos tendrán una duración de dos años, aunque podrán ser renovados posteriormente.
Read more...
About the Platform
The Spanish Nanomedicine Platform is an initiative that aims to bring together the main Spanish players in research, industry and administration, to promote a common strategy in this highly multidisciplinary area.
To promote and facilitate public-private partnerships in research and innovation in nanomedicine in Spain, with the aim of accelerating the development of innovative therapeutics and diagnostics based on the capabilities offered by nanotechnology applied to health care.
The Spanish Platform for Nanomedicine is an instrument to coordinate entities involved in R&D+i, fundamental to the transfer of results to industry and the health system in this highly multidisciplinary field. It is also a means of connection to facilitate the internationalization of initiatives and projects, with the aim of improving the competitiveness of Spanish companies in this emerging field.Want to become a member? Form
Subscribe to the newsletter
Hoja por la INNOVACIÓN
